Metropolitan Life Insurance Company (MetLife)’s Edwards Lifesciences EW Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,461	Closed	-$2.34M	–	718
2024 Q1	$2.34M	Sell	24,461 -225	-0.9%	-$18.9K	0.1%	176
2023 Q4	$1.88M	Sell	24,686 -466	-2%	-$32.4K	0.09%	195
2023 Q3	$1.74M	Sell	25,152 -1,266	-5%	-$102K	0.09%	189
2023 Q2	$2.49M	Sell	26,418 -1,235	-4%	-$107K	0.12%	147
2023 Q1	$2.29M	Sell	27,653 -8,106	-23%	-$637K	0.12%	152
2022 Q4	$2.67M	Sell	35,759 -322	-0.9%	-$24.8K	0.12%	169
2022 Q3	$2.98M	Sell	36,081 -543	-1%	-$52.2K	0.14%	139
2022 Q2	$3.48M	Sell	36,624 -1,079	-3%	-$112K	0.15%	131
2022 Q1	$4.44M	Sell	37,703 -61,535	-62%	-$6.9M	0.16%	125
2021 Q4	$12.9M	Sell	99,238 -2,370	-2%	-$276K	0.17%	97
2021 Q3	$11.5M	Sell	101,608 -3,185	-3%	-$364K	0.17%	103
2021 Q2	$10.9M	Sell	104,793 -3,700	-3%	-$349K	0.15%	106
2021 Q1	$9.07M	Sell	108,493 -6,153	-5%	-$520K	0.14%	125
2020 Q4	$10.5M	Sell	114,646 -3,658	-3%	-$303K	0.16%	109
2020 Q3	$9.44M	Sell	118,304 -4,563	-4%	-$356K	0.16%	104
2020 Q2	$8.49M	Buy	122,867 +1,460	+1%	+$104K	0.15%	118
2020 Q1	$7.63M	Sell	121,407 -1,740	-1%	-$125K	0.16%	117
2019 Q4	$9.58M	Sell	123,147 -444	-0.4%	-$34.7K	0.15%	120
2019 Q3	$9.06M	Sell	123,591 -420	-0.3%	-$29.5K	0.15%	117
2019 Q2	$7.64M	Buy	124,011 +6,537	+6%	+$395K	0.13%	142
2019 Q1	$7.49M	Sell	117,474 -5,004	-4%	-$286K	0.14%	133
2018 Q4	$6.25M	Sell	122,478 -678	-0.6%	-$34.3K	0.13%	144
2018 Q3	$7.15M	Sell	123,156 -3,357	-3%	-$164K	0.12%	146
2018 Q2	$6.14M	Buy	126,513 +1,452	+1%	+$67.8K	0.1%	181
2018 Q1	$5.82M	Sell	125,061 -21	-0%	-$912	0.08%	192
2017 Q4	$4.7M	Sell	125,082 -202,065	-62%	-$7.42M	0.06%	229
2017 Q3	$11.9M	Sell	327,147 -2,355	-0.7%	-$89.8K	0.07%	232
2017 Q2	$13M	Sell	329,502 -9,726	-3%	-$355K	0.09%	208
2017 Q1	$10.6M	Sell	339,228 -6,531	-2%	-$204K	0.07%	250
2016 Q4	$10.8M	Sell	345,759 -8,313	-2%	-$269K	0.08%	242
2016 Q3	$14.2M	Sell	354,072 -2,763	-0.8%	-$104K	0.1%	185
2016 Q2	$11.9M	Sell	356,835 -8,418	-2%	-$288K	0.09%	219
2016 Q1	$10.7M	Sell	365,253 -6,588	-2%	-$182K	0.08%	233
2015 Q4	$9.79M	Sell	371,841 -3,531	-0.9%	-$91.7K	0.08%	254
2015 Q3	$8.89M	Sell	375,372 -6,570	-2%	-$159K	0.06%	279
2015 Q2	$9.07M	Buy	381,942 +2,712	+0.7%	+$61.2K	0.06%	292
2015 Q1	$9M	Sell	379,230 -2,034	-0.5%	-$45.6K	0.07%	287
2014 Q4	$8.09M	Sell	381,264 -2,688	-0.7%	-$54K	0.06%	333
2014 Q3	$6.54M	Sell	383,952 -4,350	-1%	-$68.7K	0.05%	384
2014 Q2	$5.55M	Sell	388,302 -24,714	-6%	-$335K	0.04%	491
2014 Q1	$5.11M	Sell	413,016 -16,092	-4%	-$186K	0.04%	524
2013 Q4	$4.7M	Sell	429,108 -13,794	-3%	-$155K	0.03%	547
2013 Q3	$5.14M	Sell	442,902 -5,994	-1%	-$70.1K	0.04%	477
2013 Q2	$5.03M	Buy	+448,896	New	+$5.31M	0.04%	450

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Metropolitan Life Insurance Company (MetLife)'s EW Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 24,461 shares — an estimated $2.34M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EW in Q2 2013 and held it in 44 quarters. The position peaked at $14.2M in Q3 2016. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 24,461 Edwards Lifesciences shares in Q2 2024, an estimated $2.34M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Edwards Lifesciences in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Edwards Lifesciences position peaked at $14.2M in Q3 2016.
1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.